Search

Your search keyword '"Neeff H"' showing total 183 results
Start Over Author "Neeff H"
183 results on '"Neeff H"'

5. Interobserver variability in target volume delineation of hepatocellular carcinoma: An analysis of the working group “Stereotactic Radiotherapy” of the German Society for Radiation Oncology (DEGRO)

Author

Gkika, E., Tanadini-Lang, S., Kirste, S., Holzner, P. A., Neeff, H. P., Rischke, H. C., Reese, T., Lohaus, F., Duma, M. N., Dieckmann, K., Semrau, R., Stockinger, M., Imhoff, D., Kremers, N., Häfner, M. F., Andratschke, N., Nestle, U., Grosu, A. L., Guckenberger, M., and Brunner, T. B.

Published
2017
Full Text
View/download PDF

6. Contemporary management of locally advanced and recurrent rectal cancer: views from the PelvEx collaborative

Author

Kelly M. E., O’Sullivan N. J., Fahy M. R., Aalbers A. G. J., Abdul Aziz N., Abecasis N., Abraham-Nordling M., Abu Saadeh F., Akiyoshi T., Alberda W., Albert M., Andric M., Angeles M. A., Angenete E., Antoniou A., Auer R., Austin K. K., Aytac E., Aziz O., Bacalbasa N., Baker R. P., Bali M., Baransi S., Baseckas G., Bebington B., Bedford M., Bednarski B. K., Beets G. L., Berg P. L., Bergzoll C., Beynon J., Biondo S., Boyle K., Bordeianou L., Brecelj E., Bremers A. B., Brunner M., Buchwald P., Bui A., Burgess A., Burger J. W. A., Burling D., Burns E., Campain N., Carvalhal S., Castro L., Caycedo-Marulanda A., Ceelen W., Chan K. K. L., Chang G. J., Chang M., Chew M. H., Chok A. Y., Chong P., Clouston H., Codd M., Collins D., Colquhoun A. J., Constantinides J., Corr A., Coscia M., Cosimelli M., Cotsoglou C., Coyne P. E., Croner R. S., Damjanovich L., Daniels I. R., Davies M., Delaney C. P., de Wilt J. H. W., Denost Q., Deutsch C., Dietz D., Domingo S., Dozois E. J., Drozdov E., Duff M., Eglinton T., Enriquez-Navascues J. M., Espín-Basany E., Evans M. D., Eyjólfsdóttir B., Fearnhead N. S., Ferron G., Fichtner-Feigl S., Flatmark K., Fleming F. J., Flor B., Folkesson J., Frizelle F. A., Funder J., Gallego M. A., Gargiulo M., García-Granero E., García-Sabrido J. L., Gava V. G., Gentilini L., George M. L., George V., Georgiou P., Ghosh A., Ghouti L., Gil-Moreno A., Giner F., Ginther D. N., Glyn T., Glynn R., Golda T., Griffiths B., Harris D. A., Hanchanale V., Harji D. P., Harris C., Helewa R. M., Hellawell G., Heriot A. G., Hochman D., HohenbergerW., Holm T., Hompes R., Hornung B., Hurton S., Hyun E., Ito M., Iversen L. H., Jenkins J. T., Jourand K., Kaffenberger S., Kandaswamy G. V., Kapur S., Kanemitsu Y., Kazi M., Kelley S. R., Keller D. S., Ketelaers S. H. J., Khan M. S., Kiran R. P., Kim H., Kim H. J., Koh C. E., Kok N. F. M., Kokelaar R., Kontovounisios C., Kose F., Koutra M., Kristensen H. Ø., Kroon H. M., Kumar S., Kusters M., Lago V., Lampe B., Lakkis Z., Larach J. T., Larkin J. O., Larsen S. G., Larson D. W., Law W. L., Lee P. J., Limbert M., Loria A., Lydrup ML., Lyons A., Lynch A. C., Maciel J., Manfredelli S., Mann C., Mantyh C., Mathis K. L., Marques C. F. S., Martinez A., Martling A., Mehigan B. J., MeijerinkW. J. H. J., Merchea A., Merkel S., Mehta A. M., Mikalauskas S., McArthur D. R., McCormick J. J., McCormick P., McDermott F. D., McGrath J. S., Malde S., Mirnezami A., Monson J. R. T., Navarro A. S., Neeff H., Negoi I., Neto J. W. M., Ng J. L., Nguyen B., Nielsen M. B., Nieuwenhuijzen G. A. P., Nilsson P. J., Nordkamp S., Nugent T., Oliver A., O’Dwyer S. T., Paarnio K., Palmer G., Pappou E., Park J., Patsouras D., Peacock O., Pellino G., Peterson A. C., Pfeffer F., Pinson J., Poggioli G., Proud D., Quinn M., Quyn A., Rajendran N., Radwan R. W., Rao C., Rasheed S., Rausa E., Regenbogen S. E., Reims H. M., Renehan A., Rintala J., Rocha R., Rochester M., Rohila J., Rothbarth J., Rottoli M., Roxburgh C., Rutten H. J. T., Safar B., Sagar P. M., Sahai A., Saklani A., Sammour T., Sayyed R., Schizas A. M. P., Schwarzkopf E., Scripcariu D., Scripcariu V., Selvasekar C., Shaikh I., Simpson A., Skeie-Jensen T., Smart N. J., Smart P., Smith J. J., Solbakken A. M., Solomon M. J., Sørensen M. M., Sorrentino L., Steele S. R., Steffens D., Stitzenberg K., Stocchi L., Stylianides N. A., Swartling T., Spasojevic M., Sumrien H., Sutton P. A., Swartking T., Takala H., Tan E. J., Taylor C., Taylor D., Tekin A., Tekkis P. P., Teras J., Thaysen H. V., Thurairaja R., Thorgersen E. B., Tiernan J., Toh E. L., Tolenaar J., Tsarkov P., Tsukada Y., Tsukamoto S., Tuech J. J., Turner W. H., Tuynman J. B., Valente M., van Ramshorst G. H., van Rees J., van Zoggel D., Vasquez-JimenezW., Vather R., Verhoef C., Vierimaa M., Vizzielli G., Voogt E. L. K., Uehara K., Urrejola G., Wakeman C., Warrier S. K., Wasmuth H. H., Waters P. S., Weber K., Weiser M. R., Wheeler J. M. D., Wild J., Williams A., Wilson M., Wolthuis A., Yano H., Yip B., Yoo R. N., Zappa M. A., Winter D. C., and Kelly M.E., O’Sullivan N.J., Fahy M.R., Aalbers A.G.J., Abdul Aziz N., Abecasis N., Abraham-Nordling M., Abu Saadeh F., Akiyoshi T., Alberda W., Albert M., Andric M., Angeles M.A., Angenete E., Antoniou A., Auer R., Austin K.K., Aytac E., Aziz O., Bacalbasa N., Baker R.P., Bali M., Baransi S., Baseckas G., Bebington B., Bedford M., Bednarski B.K., Beets G.L., Berg P.L., Bergzoll C., Beynon J., Biondo S., Boyle K., Bordeianou L., Brecelj E., Bremers A.B., Brunner M., Buchwald P., Bui A., Burgess A., Burger J.W.A., Burling D., Burns E., Campain N., Carvalhal S., Castro L., Caycedo-Marulanda A., Ceelen W., Chan K.K.L., Chang G.J., Chang M., Chew M.H., Chok A.Y., Chong P., Clouston H., Codd M., Collins D., Colquhoun A.J., Constantinides J., Corr A., Coscia M., Cosimelli M., Cotsoglou C., Coyne P.E., Croner R.S., Damjanovich L., Daniels I.R., Davies M., Delaney C.P., de Wilt J.H.W., Denost Q., Deutsch C., Dietz D., Domingo S., Dozois E.J., Drozdov E., Duff M., Eglinton T., Enriquez-Navascues J.M., Espín-Basany E., Evans M.D., Eyjólfsdóttir B., Fearnhead N.S., Ferron G., Fichtner-Feigl S., Flatmark K., Fleming F.J., Flor B., Folkesson J., Frizelle F.A., Funder J., Gallego M.A., Gargiulo M., García-Granero E., García-Sabrido J.L., Gargiulo M., Gava V.G., Gentilini L., George M.L., George V., Georgiou P., Ghosh A., Ghouti L., Gil-Moreno A., Giner F., Ginther D.N., Glyn T., Glynn R., Golda T., Griffiths B., Harris D.A., Hanchanale V., Harji D.P., Harris C., Helewa R.M., Hellawell G., Heriot A.G., Hochman D., HohenbergerW., Holm T., Hompes R., Hornung B., Hurton S., Hyun E., Ito M., Iversen L.H., Jenkins J.T., Jourand K., Kaffenberger S., Kandaswamy G.V., Kapur S., Kanemitsu Y., Kazi M., Kelley S.R., Keller D.S., Ketelaers S.H.J., Khan M.S., Kiran R.P., Kim H., Kim H.J., Koh C.E., Kok N.F.M., Kokelaar R., Kontovounisios C., Kose F., Koutra M., Kristensen H.Ø., Kroon H.M., Kumar S., Kusters M., Lago V., Lampe B., Lakkis Z., Larach J.T., Larkin J.O., Larsen S.G., Larson D.W., Law W.L., Lee P.J., Limbert M., Loria A., Lydrup ML., Lyons A., Lynch A.C., Maciel J., Manfredelli S., Mann C., Mantyh C., Mathis K.L., Marques C.F.S., Martinez A., Martling A., Mehigan B.J., MeijerinkW.J.H.J., Merchea A., Merkel S., Mehta A.M., Mikalauskas S., McArthur D.R., McCormick J.J., McCormick P., McDermott F.D., McGrath J.S., Malde S., Mirnezami A., Monson J.R.T., Navarro A.S., Neeff H., Negoi I., Neto J.W.M., Ng J.L., Nguyen B., Nielsen M.B., Nieuwenhuijzen G.A.P., Nilsson P.J., Nordkamp S., Nugent T., Oliver A., O’Dwyer S.T., Paarnio K., Palmer G., Pappou E., Park J., Patsouras D., Peacock O., Pellino G., Peterson A.C., Pfeffer F., Pinson J., Poggioli G., Proud D., Quinn M., Quyn A., Rajendran N., Radwan R.W., Rajendran N., Rao C., Rasheed S., Rausa E., Regenbogen S.E., Reims H.M., Renehan A., Rintala J., Rocha R., Rochester M., Rohila J., Rothbarth J., Rottoli M., Roxburgh C., Rutten H.J.T., Safar B., Sagar P.M., Sahai A., Saklani A., Sammour T., Sayyed R., Schizas A.M.P., Schwarzkopf E., Scripcariu D., Scripcariu V., Selvasekar C., Shaikh I., Simpson A., Skeie-Jensen T., Smart N.J., Smart P., Smith J.J., Solbakken A.M., Solomon M.J., Sørensen M.M., Sorrentino L., Steele S.R., Steffens D., Stitzenberg K., Stocchi L., Stylianides N.A., Swartling T., Spasojevic M., Sumrien H., Sutton P.A., Swartking T., Takala H., Tan E.J., Taylor C., Taylor D., Tekin A., Tekkis P.P., Teras J., Thaysen H.V., Thurairaja R., Thorgersen E.B., Tiernan J., Toh E.L., Tolenaar J., Tsarkov P., Tsukada Y., Tsukamoto S., Tuech J.J., Turner W.H., Tuynman J.B., Valente M., van Ramshorst G.H., van Rees J., van Zoggel D., Vasquez-JimenezW., Vather R., Verhoef C., Vierimaa M., Vizzielli G., Voogt E.L.K., Uehara K., Urrejola G., Wakeman C., Warrier S.K.,Wasmuth H.H.,Waters P.S.,Weber K.,Weiser M.R., Wheeler J.M.D.,Wild J., Williams A., Wilson M., Wolthuis A., Yano H., Yip B., Yoo R.N., Zappa M.A., Winter D.C.

Subjects
Cancer Research, perioperative care, ENHANCED RECOVERY, diagnostic, EXENTERATION, surgical management, surgical outcomes, recurrent rectal cancer, SDG 3 - Good Health and Well-being, locally advanced rectal cancer, QUALITY-OF-LIFE, Medicine and Health Sciences, diagnostics, 1112 Oncology and Carcinogenesis, PATHOLOGICAL COMPLETE RESPONSE, rectal cancer, SURGICAL TECHNIQUES, OUTCOMES, Science & Technology, HYPERTHERMIC INTRAPERITONEAL, PelvEx Collaborative, CHEMOTHERAPY, WHOLE-BODY MRI, NEOADJUVANT CHEMORADIOTHERAPY, Oncology, quality of life, CYTOREDUCTIVE SURGERY, HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY, Life Sciences & Biomedicine
Abstract

Pelvic exenteration is a complex operation performed for locally advanced and recurrent pelvic cancers. The goal of surgery is to achieve clear margins, therefore identifying adjacent or involved organs, bone, muscle, nerves and/or vascular structures that may need resection. While these extensive resections are potentially curative, they can be associated with substantial morbidity. Recently, there has been a move to centralize care to specialized units, as this facilitates better multidisciplinary care input. Advancements in pelvic oncology and surgical innovation have redefined the boundaries of pelvic exenterative surgery. Combined with improved neoadjuvant therapies, advances in diagnostics, and better reconstructive techniques have provided quicker recovery and better quality of life outcomes, with improved survival This article provides highlights of the current management of advanced pelvic cancers in terms of surgical strategy and potential future developments.

Published
2022

19. Der gluteale Faltenlappen als alternative Option zur Rekonstruktion perinealer Defekte

Author

Bannasch, H, Lampert, F, Stark, GB, Koulaxouzidis, G, Penna, V, Witzel, C, Aigner, F, Pratschke, J, and Neeff, H

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Ziel: Perineale Defekte nach anorektaler Tumorresektion stellen eine rekonstruktive Herausforderung dar. Trotz ihrer Zuverlässigkeit haben Lappenplastiken mit Verwendung des Musculus rectus abdominis eine Reihe immanenter Nachteile. Lokale, perforatorbasierte Lappenplastiken können hier eine[zum vollständigen Text gelangen Sie über die oben angegebene URL], 49. Jahrestagung der Deutschen Gesellschaft der Plastischen, Rekonstruktiven und Ästhetischen Chirurgen (DGPRÄC), 23. Jahrestagung der Vereinigung der Deutschen Ästhetisch-Plastischen Chirurgen (VDÄPC)

Published
2018
Full Text
View/download PDF

27. Supplementary Material for: Autosomal Dominant Polycystic Kidney Disease: Prevalence of Renal Neoplasias in Surgical Kidney Specimens

Author

Jilg, C.A., Drendel, V., Bacher, J., Pisarski, P., Neeff, H., Drognitz, O., Schwardt, M., Gläsker, S., Malinoc, A., Erlic, Z., Nunez, M., Weber, A., Azurmendi, P., Schultze-Seemann, W., Werner, M., and Neumann H.P.H.

Subjects
urogenital system, urologic and male genital diseases, female genital diseases and pregnancy complications
Abstract

Background: The role of autosomal dominant polycystic kidney disease (ADPKD) as a risk factor for renal cell carcinoma (RCC) is still under discussion. Data on prevalence of RCC in ADPKD are limited, especially on a large population scale. The aim of this study was to analyze the prevalence of RCC in ADPKD kidneys and characterize the clinical features of this coincidence. Methods: Based on our histopathological registry for ADPKD and the Else Kröner-Fresenius Registry, we retrospectively reviewed malignant and benign renal lesions in patients with ADPKD who had undergone renal surgery from 1988 to 2011. Results: 240 ADPKD patients underwent 301 renal surgeries. Mean age at surgery was 54 years. Overall, 16 malignant and 11 benign lesions were analyzed in 301 kidneys (5.3%; 3.7%), meaning that 12/240 (5%; 1:20) patients presented with malignant renal lesions. 66.7% (8/12) of these patients had undergone dialysis prior to surgery. We found 10/16 (63%) papillary RCC, 5/16 (31%) clear cell RCC, and 1/16 (6%) papillary noninvasive urothelial cancer. Regarding all renal lesions, 6/17 (35.3%) patients had more than one histological finding in their kidneys. In 2 cases, metachronous metastases were removed. Mean follow-up was 66.7 months. Conclusion: Kidney-related prevalence of RCC in ADPKD kidneys was surprisingly high. Whether or not this is due to chronic dialysis or due to the underlying disease is still speculative. Like other cystic renal diseases with an increased risk for RCC, the attending physician should be aware of the malignant potential of ADPKD, especially with concomitant dialysis.

Published
2017
Full Text
View/download PDF

28. Das intrahepatische Cholangiokarzinom

Author

Neeff, H. P., primary, Holzner, P. A., additional, Menzel, M., additional, Bronsert, P., additional, Klock, A., additional, Lang, S. A., additional, Fichtner-Feigl, S., additional, Hopt, U. T., additional, and Makowiec, F., additional

Published
2018
Full Text
View/download PDF

29. Interobserver variability in the target delineation of hepatocellular carcinoma.

Author

Gkika, E., Tandini-Lang, S., Kirste, S., Holzner, P., Neeff, H. P., Rischke, H. C., Reese, T., Lohaus, F., Duma, M. N., Dieckmann, K., Semrau, R., Stockinger, M., Imhoff, D., Kremers, N., Haefner, M., Andratschke, N., Nestle, U., Grosu, A. L., Guckenberger, M., Brunner, T., Gkika, E., Tandini-Lang, S., Kirste, S., Holzner, P., Neeff, H. P., Rischke, H. C., Reese, T., Lohaus, F., Duma, M. N., Dieckmann, K., Semrau, R., Stockinger, M., Imhoff, D., Kremers, N., Haefner, M., Andratschke, N., Nestle, U., Grosu, A. L., Guckenberger, M., and Brunner, T.

Published
2017

30. Interobserver variability in target volume delineation of hepatocellular carcinoma

Author

Gkika, E., Tanadini-Lang, S., Kirste, S., Holzner, P. A., Neeff, H. P., Rischke, H. C., Reese, T., Lohaus, F., Duma, M. N., Dieckmann, K., Semrau, R., Stockinger, M., Imhoff, D., Kremers, N., Haefner, M. F., Andratschke, N., Nestle, U., Grosu, A. L., Guckenberger, M., Brunner, T. B., Gkika, E., Tanadini-Lang, S., Kirste, S., Holzner, P. A., Neeff, H. P., Rischke, H. C., Reese, T., Lohaus, F., Duma, M. N., Dieckmann, K., Semrau, R., Stockinger, M., Imhoff, D., Kremers, N., Haefner, M. F., Andratschke, N., Nestle, U., Grosu, A. L., Guckenberger, M., and Brunner, T. B.

Abstract

Background Definition of gross tumor volume (GTV) in hepatocellular carcinoma (HCC) requires dedicated imaging in multiple contrast medium phases. The aim of this study was to evaluate the interobserver agreement (IOA) in gross tumor delineation of HCC in a multicenter panel. Methods The analysis was performed within the Stereotactic Radiotherapy working group of the German Society for Radiation Oncology (DEGRO). The GTVs of three anonymized HCC cases were delineated by 16 physicians from nine centers using multiphasic CT scans. In the first case the tumor was well defined. The second patient had multifocal HCC (one conglomerate and one peripheral tumor) and was previously treated with transarterial chemoembolization (TACE). The peripheral lesion was adjacent to the previous TACE site. The last patient had an extensive HCC with a portal vein thrombosis (PVT) and an inhomogeneous liver parenchyma due to cirrhosis. The IOA was evaluated according to Landis and Koch. Results The IOA for the first case was excellent (kappa: 0.85); for the second case moderate (kappa: 0.48) for the peripheral tumor and substantial (kappa: 0.73) for the conglomerate. In the case of the peripheral tumor the inconsistency is most likely explained by the necrotic tumor cavity after TACE caudal to the viable tumor. In the last case the IOA was fair, with a kappa of 0.34, with significant heterogeneity concerning the borders of the tumor and the PVT. Conclusion The IOA was very good among the cases were the tumor was well defined. In complex cases, where the tumor did not show the typical characteristics, or in cases with Lipiodol (Guerbet, Paris, France) deposits, IOA agreement was compromised.

Published
2017

31. Intrahepatic Cholangiocarcinoma: An increasing entity: Results after 79 resections at a university center for hepatic surgery

Author

Neeff, H, Holzner, P, Menzel, M, Hopt, UT, and Makowiec, F

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Background: Intrahepatic cholangiocarcinoma (ICC) is a rare entity. In the western world the incidence is below one in 100.000. Yet, there has been a sharp increase over the past 30 years, more than doubling the incidence. Diagnosis is often delayed due to oligosymptomatic growth. Survival is poor and[for full text, please go to the a.m. URL], 133. Kongress der Deutschen Gesellschaft für Chirurgie

Published
2016
Full Text
View/download PDF

34. Interobserver Variability in the Target Volume Definition for Hepatocellular Carcinomas with and without portal vein Thrombosis

Author

Gkika, E., Lang, S., Kirste, S., Holzner, P., Neeff, H., Rischke, C., Reese, T., Lohaus, F., Duma, M. -N., Dieckmann, K., Semrau, R., Stockinger, M., Nestle, U., Grosu, A. -L., Guckenberger, M., Brunner, T., Gkika, E., Lang, S., Kirste, S., Holzner, P., Neeff, H., Rischke, C., Reese, T., Lohaus, F., Duma, M. -N., Dieckmann, K., Semrau, R., Stockinger, M., Nestle, U., Grosu, A. -L., Guckenberger, M., and Brunner, T.

Published
2016

36. Die Notfalllaparotomie beim Leberzirrhotiker: Wenn es nicht die Galle ist? Langzeitergebnisse bei 68 Patienten

Author

Neeff, H, Holzner, P, Schultheiß, M, Thimme, R, Hopt, UT, and Makowiec, F

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Einleitung: Notfalleingriffe bei Patienten mit Leberzirrhose sind von einer hohen perioperativen Letalität gekennzeichnet. Auch Patienten, die das Krankenhaus verlassen können, weisen im Verlauf noch eine hohe Sterblichkeit auf. Material und Methoden: Es wurden 194 Patienten mit Leberzirrhose[for full text, please go to the a.m. URL], 131. Kongress der Deutschen Gesellschaft für Chirurgie

Published
2014
Full Text
View/download PDF

38. Risikofaktoren für Kurz- und Langzeitmortalität nach allgemeinchirurgischen Operationen bei Patienten mit Leberzirrhose

Author

Makowiec, F, Streule, G, Neeff, H, Keck, T, and Hopt, UT

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Einleitung: Im Gegensatz zu elektiven Lebereingriffen ist die Mortalität nach abdominalchirurgischen Eingriffen bei Patienten mit Leberzirrhose hoch. Eine Analyse von Risikofaktoren für die Mortalität früh und spät nach OP ist im deutschsprachigen Raum noch nicht publiziert [for full text, please go to the a.m. URL], 129. Kongress der Deutschen Gesellschaft für Chirurgie

Published
2012
Full Text
View/download PDF

39. Ergebnisse nach Resektion hepatozellulärer Karzinome

Author

Neeff, H, Drognitz, O, Klock, A, Makowiec, F, and Hopt, UT

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Einleitung: Das hepatozelluläre Karzinom (HCC) ist in Mitteleuropa stetig zunehmend. Die Therapiemöglichkeiten bei HCC sind abhängig vom Ausmaß der Erkrankung und umfassen auch eine Resektion. Da chirurgische Ergebnisse aus Deutschland noch wenig bekannt sind analysierten wir unsere[for full text, please go to the a.m. URL], 127. Kongress der Deutschen Gesellschaft für Chirurgie

Published
2010
Full Text
View/download PDF

40. Prognostische Faktoren nach Leberresektion kolorektaler Metastasen: eine Analyse von 264 operierten Patienten

Author

Drognitz, O, Neeff, H, Klock, A, Hopt, UT, and Makowiec, F

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Einleitung: Die Resektion von Lebermetastasen hat aufgrund guter Ergebnisse einen festen Platz in der Therapie des metastasierten kolorektalen Karzinoms erreicht. Die Kenntnis prognostischer Parameter spielt eine wichtige Rolle ob und wann im Rahmen der multimodalen Therapie operiert werden soll. Wir[for full text, please go to the a.m. URL], 127. Kongress der Deutschen Gesellschaft für Chirurgie

Published
2010
Full Text
View/download PDF

50. Interobservervariabilität bei der Zielvolumendefinition für hepatozelluläre Karzinome : Eine Analyse der Arbeitsgruppe „Stereotaktische Radiotherapie“ der Deutschen Gesellschaft für Radioonkologie (DEGRO).

Author

Gkika, E., Tanadini-Lang, S., Kirste, S., Holzner, P., Neeff, H., Rischke, H., Reese, T., Lohaus, F., Duma, M., Dieckmann, K., Semrau, R., Stockinger, M., Imhoff, D., Kremers, N., Häfner, M., Andratschke, N., Nestle, U., Grosu, A., Guckenberger, M., and Brunner, T.

Subjects
ANTHROPOMETRY, COMPARATIVE studies, COMPUTED tomography, HEPATOCELLULAR carcinoma, LIVER tumors, RESEARCH methodology, MEDICAL cooperation, RESEARCH, RESEARCH evaluation, EVALUATION research, RESEARCH bias
Abstract

Copyright of Strahlentherapie und Onkologie is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results